Outlook Therapeutics, Inc. Insider Transactions
Outlook Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Syntone Ventures LLC
10 percent owner |
Buy | 714,286 @ $7.00 | $5.00 M | 1,705,438 | 04/15/2024 | 04/17/2024 | |
|
Syntone Ventures LLC
10 percent owner |
Buy | 1,071,429 @ $7.70 | $8.25 M | 1,071,429 | 04/15/2024 | 04/17/2024 | |
|
Haddadin Yezan Munther
Director |
Buy | 1,882 @ $11.82 | $22,242 | 5,049 | 03/28/2024 | 03/29/2024 | |
|
Evanson Jeff
CHIEF COMMERCIAL OFFICER |
Buy | 62,484 @ $0.42 | $26,243 | 808,459 | 03/07/2024 | 03/11/2024 | |
|
Dagnon Terry
Chief Operations Officer |
Sell | 520,000 @ $1.14 | $590,200 | 653,058 | 04/20/2023 | 04/21/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Outlook Therapeutics, Inc. FAQ's
The list of insiders at Outlook Therapeutics, Inc. includes Haddadin Yezan Munther, Syntone Ventures LLC.
Insiders have purchased a total of 1.79 M Outlook Therapeutics, Inc. shares in the last 12 months for a total of 13.27 M.
The following insiders have purchased Outlook Therapeutics, Inc. shares in the last 12 months: Haddadin Yezan Munther ($22,242), Syntone Ventures LLC ($13.25 M),